The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the combination of balixafortide (CXCR4 inhibitor) and eribulin in HER2-negative metastatic breast cancer (MBC) patients (pts).
 
Marta Gil-Martin
No Relationships to Disclose
 
Patricia Gomez Pardo
No Relationships to Disclose
 
Sara Lopez-Tarruella
Honoraria - Roche
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Celgene; Pierre Fabre; Roche
 
Luis Manso
No Relationships to Disclose
 
Jose Alejandro Perez-Fidalgo
Speakers' Bureau - AstraZeneca; Ipsen; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche; Sandoz
 
Foluso Olabisi Ademuyiwa
Research Funding - Abbvie (Inst); Medivation (Inst)
 
Ingrid A. Mayer
Consulting or Advisory Role - AstraZeneca; Novartis
Research Funding - Novartis; Pfizer
 
Timothy J. Pluard
Consulting or Advisory Role - Bayer/Onyx
Speakers' Bureau - Genentech/Roche; NanoString Technologies
 
Maria Martinez Garcia
Speakers' Bureau - Celgene; Pierre Fabre; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Peter A. Kaufman
Consulting or Advisory Role - Eisai
Research Funding - Eisai; Polyphor
 
Linda T. Vahdat
Consulting or Advisory Role - Berg Pharma
Speakers' Bureau - Eisai
Research Funding - Abbvie (Inst); AstraZeneca (Inst); celldex (Inst); Clovis Oncology (Inst); Galena Biopharma (Inst); Immunomedics (Inst); millennium (Inst); Optimer Biotechnology (Inst); PharmaMar (Inst); Polyphor (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)
 
Leon W. Hooftman
Employment - Polyphor
Stock and Other Ownership Interests - Ablynx; Argenx
Research Funding - Polyphor
 
Barbara Romagnoli
Employment - Polyphor
Patents, Royalties, Other Intellectual Property - Polyphor
Travel, Accommodations, Expenses - Polyphor
 
Cristina Hernando
No Relationships to Disclose
 
Katherine N. Weilbaecher
Research Funding - Novartis (Inst)
 
Eva M. Ciruelos
No Relationships to Disclose
 
Miguel Martin
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst)
 
Sonia Pernas Simon
Consulting or Advisory Role - Celgene; Pierre Fabre; Roche
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Celgene; Cellestia Biotech; Roche/Genentech